batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Pfizer’s CD47 nightmare deepens 1 July 2025 After Astra/EsoBiotec, AbbVie pays $2bn for Capstan 30 June 2025 Calico looks to China 30 June 2025 A curious turn for VISTA 27 June 2025 Pfizer goes early with mevrometostat 25 June 2025 Kymera's oncology comeback, courtesy of Gilead 25 June 2025 Syndax and Kura go head to head again 25 June 2025 A new SERD in the pivotal pipeline 19 June 2025 Load More